Cadila Pharmaceuticals, on Thursday, launched a new lung cancer drug, Mycidac-C.

The Supreme Court on Monday issued notice to PATH, an international NGO working in the health sector, on a PIL alleging that it indulged in unethical conduct of clinical trials in collaboration wit

The National Green Tribunal, Southern Bench on Monday ordered notice to Andhra Pradesh Government on a plea to restrain bulk drug manufacturing industries from causing pollution to Nakka Vagu river

The bench tagged the case with other petitions on clinical trials being heard by a different bench

The Supreme Court today issued notice to PATH, an international NGO working in the health sector, on a PIL alleging that it indulged in unethical conduct of clinical trials in collaboration with ICMR between 2009-10 in Andhra Pradesh and Gujarat.

Initiates petition in change.org asking SC to allow review and approval process to resume

People for the Advancement of Clinical Research, (PACR) India, a group that claims to comprise ordinary healthy citizens, patients, government officials, health enterprise professionals, educators and patient advocacy groups have initiated a petition in the popular advocacy site change-.org asking the Supreme Court to allow the review and approval process for clinical trial applications to resume.

Goa State Pollution Control Board (GSPCB) has issued showcause notice to Sandu pharmaceuticals limited, as to why its unit at Pilerne industrial estate should not be directed to suspend or close it

An official at PCB confirmed development saying they had issued closure orders on Wednesday against Unit 5 of Mylan

The Andhra Pradesh Pollution Control Board (APPCB) has issued a closure order against one of the manufacturing units owned by US generics drug maker Mylan Inc for violating effluent treatment norms.

Clinical trials in the country must be to help the people and must not be allowed for the benefit of multinational companies, the Supreme Court said on Monday, while holding that the norms formulat

A vaccine against malaria could be introduced in the world’s worst-hit countries in 2015, after the latest trial of a treatment produced by Britain’s biggest drug company reduced the number of case